Janux Therapeutics Inc (JANX)

EBITDA Margin

-419.55%

TTM · Period ending:

JANX logo

JANX EBITDA Margin

Latest reported-419.55%
JANX TTM EBITDA Margin (-1980.53% → -419.55%)
High-resolution chart · PNG

JANX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Janux Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-419.5458%
-819.1874%
-1,115.96%
-998.22%
-23,589.7494%
-810.7862%
-632.1685%
-447.9807%
-277.4906%
-735.0075%
-696.9937%
-717.7631%
-852.1448%
-726.4359%
-722.457%
-811.4317%
-805.4689%
-899.9794%
-895.2158%
-1,031.8159%
-1,318.9095%
-1,980.5263%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.